Symphony Asset Management’s GSK GSK Stock Holding History

Symphony Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-16,991	Closed	-$980K	–	445
2015 Q1	$980K	Buy	+16,991	New	+$974K	0.11%	183

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Symphony Asset Management's GSK Position: Q2 2015 in Review

Symphony Asset Management sold out of GSK (GSK) in Q2 2015, closing a stake of 16,991 shares — an estimated $980K sold.

Symphony Asset Management first reported a position in GSK in Q1 2015 and held it in 1 quarter. The position peaked at $980K in Q1 2015. 719 funds tracked by Wall St. Rank hold GSK as of Q2 2015.

Symphony Asset Management reported no remaining GSK position as of Q2 2015 after selling out during the quarter.
Symphony Asset Management sold 16,991 GSK shares in Q2 2015, an estimated $980K.
Symphony Asset Management first reported a position in GSK in Q1 2015 and held it in 1 quarter.
Symphony Asset Management's GSK position peaked at $980K in Q1 2015.
719 funds tracked by Wall St. Rank held GSK as of Q2 2015.

Based on Symphony Asset Management's 13F filing for Q2 2015, filed 12 Aug 2015.